GGrantIndex
Sort

1,049,261 grants matching t cell

Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.

$2,243,861
Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2024 · AG

Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies

$2,243,727
Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Pathogenesis, Transmission and Detection of Zoonotic Prion Diseases

$2,243,704
Claudio Soto · University Of Texas Hlth Sci Ctr Houston · P01 · FY2016 · AI

Hyaluronan Matrices in Vascular Pathologies

$2,243,684
Vincent C. Hascall · Cleveland Clinic Lerner Com-Cwru · P01 · FY2017 · HL

Center for Neuroscience Excellence

$2,243,600
Rodney L Parsons · University Of Vermont & St Agric College · P20 · FY2006 · RR

Salivary Gland Secretion Mechanisms During Normal And Altered Functional States

$2,243,578
Bruce J Baum · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE

University of Texas Southwestern Medical Center SPORE in Kidney Cancer

$2,243,520
James Brugarolas · Ut Southwestern Medical Center · P50 · FY2024 · CA

Genetic Architecture of Alzheimer’s disease Proteinopathies

$2,243,331
M. Ilyas Kamboh · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AG

Molecular and Architectural Mechanisms of Reprogramming to Pluripotency

$2,243,219
Kathrin Plath · University Of California Los Angeles · P01 · FY2012 · GM

Development of vaccines to bacterial diseases found especially in children

$2,243,180
John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD

Functional and Pharmacological Significance of Receptor Heteromers in the CNS

$2,243,133
Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2016 · DA

Targeted Gene Evolution via Replication-Transcription Conflicts

$2,243,097
Houra Merrikh · University Of Washington · DP2 · FY2013 · GM

Signaling of Endothelial Permeability and Lung Injury

$2,243,028
Asrar B. Malik · University Of Illinois At Chicago · P01 · FY2009 · HL

Integrative Pathophysiology of Solid Tumors

$2,243,002
Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2012 · CA

Illuminating the Druggable GPCR-ome

$2,242,958
Bryan L Roth · Univ Of North Carolina Chapel Hill · U24 · FY2020 · DK

Center on the Microenvironment and Metastasis

$2,242,939
Michael L Shuler · Cornell University · U54 · FY2013 · CA

Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)

$2,242,842
Kenneth E Palmer · University Of Louisville · U19 · FY2018 · AI

Arabidopsis 2010: Genomics Approaches to Finding Transcriptional Networks

$2,242,829
Philip Benfey · Duke University · · FY2002 · BIO

Early Life Stress Induced Mechanisms of Cardiovascular Disease Risk and Resilience

$2,242,725
Jennifer S Pollock · University Of Alabama At Birmingham · P01 · FY2023 · HL

Investigations of targets, mechanisms, and optimal delivery of therapeutic ketosis for functional longevity and treatment of Alzheimer's disease

$2,242,722
Gino A Cortopassi · University Of California At Davis · P01 · FY2019 · AG

Pathobiology of Macrovascular Disease in Diabetes

$2,242,721
Alan Chait · University Of Washington · P01 · FY2008 · HL

MATERIALS AND MODULES FOR LOW-COST, HIGH PERFORMANCE FUEL CELL HUMIDIFIERS

$2,242,666
Wl Gore & Associates Inc · · FY2010 · Department of Energy

A versatile approach for highly multiplexed, high-resolution imaging of endogenous molecules

$2,242,506
Linnaea E Ostroff · University Of Connecticut Storrs · RF1 · FY2022 · MH

COBRE in Digestive & Liver Disease

$2,242,500
Stephen A Duncan · Medical University Of South Carolina · P20 · FY2021 · GM

COBRE in Digestive & Liver Disease

$2,242,500
Stephen A Duncan · Medical University Of South Carolina · P20 · FY2022 · GM